HeartBeam, Inc. BEAT
0.44 USD +0.01 (+1.23%)
Nov 4, 2026, 9:51 AM EST
0.42 Day range 0.4487
0.355 52-week range 4.00
- YTD
- -81.86%
- 1 year
- -73.61%
- Market cap
- 24.53M
- EPS (ttm)
- -0.50
- Shares out
- 26.67M
- Forward P/E
- -4.51
- YTD return
- -81.86%
- 1-year return
- -73.61%
- Volume
- 188.21K
- Avg volume
- 7.48M
- Open
- 0.4431
- Previous close
- 0.4301
- Day's range
- 0.42 – 0.4487
- 52-week range
- 0.355 – 4.00
- Beta
- -0.99
- Analysts
- Buy
- Price target
- 5.00 (+1048.4%)
2Y -1.9980 (-82.22%)
Key statistics
- Enterprise value
- 52.73M
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 3.95
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- -6.47M
- Total cash
- 9.16M
- Total debt
- 0
- Return on equity
- -113.62%
- Short % of float
- 0.58%
- 50-day average
- 2.59
- 200-day average
- 2.39
Analyst view
Consensus: buy
Buy
Price target (mean) 5.00 +1048.4% upside
Now 0.4354
- Target (low)
- 2.00
- Target (mean)
- 5.00
- Target (high)
- 8.00
Ratings (0m) 2 1 buy · 1 hold · 0 sell
- Strong buy0
- Buy1
- Hold1
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
BEAT Revenue — quarterly 0
BEAT Net income — quarterly -5.04M
BEAT EPS — quarterly -0.10
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | 0.00 | -0.19 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | -0.19 | — | — |
| May 9, 2024 | Mar 1, 2024 | 0.00 | -0.17 | — | — |
| Mar 20, 2024 | Dec 1, 2023 | -0.12 | -0.13 | -0.01 | -8.33% |
| Nov 14, 2023 | Sep 1, 2023 | -0.12 | -0.13 | -0.01 | -8.33% |
| Aug 10, 2023 | Jun 1, 2023 | -0.10 | -0.16 | -0.06 | -60.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 15, 2024 | Benchmark | reit | Speculative Buy | Speculative Buy |
| May 13, 2024 | Benchmark | reit | Speculative Buy | Speculative Buy |
| Mar 25, 2024 | Benchmark | reit | Speculative Buy | Speculative Buy |
| Nov 16, 2023 | Benchmark | reit | Speculative Buy | Speculative Buy |
| Aug 24, 2023 | Benchmark | reit | Speculative Buy | Speculative Buy |
| May 19, 2023 | Alliance Global Partners | main | Buy | Buy |
About HeartBeam, Inc.
HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.
- Sector
- Healthcare
- Industry
- Health Information Services
- Country
- United States
- Website
- heartbeam.com
News
HeartBeam to Host Third Quarter 2026 Results Conference Call on Thursday, November 12, 2026 at 4:30 p.m. Eastern Time 
HeartBeam Announces Positive Heart Attack Pilot Study Results at TCT 2026: Patient-Recorded 3D ECG Shown to Be as Accurate as Standard 12-Lead ECG 
HeartBeam to Present Results of ALIGN-ACS Study for Heart Attack Assessment at TCT 2026 on November 1, 2026 
HeartBeam Wins FDA Total Product Life Cycle Advisory Program Pilot Acceptance For Heart Attack Assessment Technology 
HeartBeam Completes Enrollment Ahead Of Schedule In 486-Patient HEADSTART-ACS Study 
HEADSTART-ACS Completes Enrollment Ahead of Schedule, the Largest Heart Attack Detection Study to Date Using HeartBeam Technology 
HeartBeam Named Contributing Partner In Launch Of EXIT-CVD Research Project, Co-Funded By European Union Innovative Health Initiative And Industry Partners 
HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome (ACS) in High-Risk Patients 
12 Health Care Stocks Moving In Tuesday's Pre-Market Session 
HeartBeam Secures FDA Designation for At-Home Heart Attack Detection System
Your note
Sign in to keep a note on BEAT — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BROUNSTEIN RICHARD D | Chief Financial Officer | Conversion of Exercise of derivative security | Feb 9, 2023 | 112,108 |
| DE URIOSTE GEORGE A. | Director | Sale | Sep 5, 2024 | 57,146 |
| ELFRINK WILLHEM P. | Director | Stock Award(Grant) | Jun 11, 2024 | 424,807 |
| FERRARI RICHARD M | Director | Stock Award(Grant) | Jun 11, 2024 | 215,377 |
| JAFF MICHAEL R. | Director | Stock Award(Grant) | Jun 11, 2024 | 75,120 |
| NELSON KENNETH WARWICK III | Director | Stock Award(Grant) | Jun 11, 2024 | 127,147 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 2.82% | 750,714 | 1.79M | Sep 29, 2024 |
| Smith Salley Wealth Management | 0.94% | 250,000 | 597.50K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.88% | 233,397 | 557.82K | Sep 29, 2024 |
| UBS Group AG | 0.60% | 160,002 | 382.40K | Sep 29, 2024 |
| Ritholtz Wealth Management | 0.52% | 139,182 | 332.64K | Sep 29, 2024 |
| O'Shaughnessy Asset Management LLC | 0.52% | 139,182 | 332.64K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.01% | 537,089 | 1.28M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.75% | 200,317 | 478.76K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.47% | 126,136 | 301.46K | Oct 30, 2024 |
| iShares Micro Cap ETF | 0.17% | 46,455 | 111.03K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.14% | 38,600 | 92.25K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.11% | 30,072 | 71.87K | Oct 30, 2024 |